141 related articles for article (PubMed ID: 20663136)
1. Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients.
Advani AS; Gibson SE; Douglas E; Jin T; Zhao X; Kalaycio M; Copelan E; Sobecks R; Sekeres M; Sungren S; Hsi ED
BMC Cancer; 2010 Jul; 10():387. PubMed ID: 20663136
[TBL] [Abstract][Full Text] [Related]
2. Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL).
Advani AS; Gibson S; Douglas E; Diacovo J; Elson P; Kalaycio M; Copelan E; Sekeres M; Sobecks R; Sungren S; Lagoo A; Rizzieri D; Hsi E
Br J Haematol; 2011 May; 153(4):504-7. PubMed ID: 21375525
[TBL] [Abstract][Full Text] [Related]
3. Preserved global histone H4 acetylation linked to ETV6-RUNX1 fusion and PAX5 deletions is associated with favorable outcome in pediatric B-cell progenitor acute lymphoblastic leukemia.
Janczar K; Janczar S; Pastorczak A; Mycko K; Paige AJ; Zalewska-Szewczyk B; Wagrowska-Danilewicz M; Danilewicz M; Mlynarski W
Leuk Res; 2015 Dec; 39(12):1455-61. PubMed ID: 26520622
[TBL] [Abstract][Full Text] [Related]
4. Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment.
Demosthenous C; Lalayanni C; Iskas M; Douka V; Pastelli N; Anagnostopoulos A
Curr Probl Cancer; 2019 Jun; 43(3):222-227. PubMed ID: 29895435
[TBL] [Abstract][Full Text] [Related]
5. Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemia.
Carraway HE; Sawalha Y; Gojo I; Lee MJ; Lee S; Tomita Y; Yuno A; Greer J; Smith BD; Pratz KW; Levis MJ; Gore SD; Ghosh N; Dezern A; Blackford AL; Baer MR; Gore L; Piekarz R; Trepel JB; Karp JE
Leuk Res; 2021 Nov; 110():106707. PubMed ID: 34563945
[TBL] [Abstract][Full Text] [Related]
6. Deficient histone acetylation in acute leukemia and the correction by an isothiocyanate.
Xiao L; Huang Y; Zhen R; Chiao JW; Liu D; Ma X
Acta Haematol; 2010; 123(2):71-6. PubMed ID: 20051681
[TBL] [Abstract][Full Text] [Related]
7. A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial.
Ribera JM; Morgades M; Montesinos P; Tormo M; Martínez-Carballeira D; González-Campos J; Gil C; Barba P; García-Boyero R; Coll R; Pedreño M; Ribera J; Mercadal S; Vives S; Novo A; Genescà E; Hernández-Rivas JM; Bergua J; Amigo ML; Vall-Llovera F; Martínez-Sánchez P; Calbacho M; García-Cadenas I; Garcia-Guiñon A; Sánchez-Sánchez MJ; Cervera M; Feliu E; Orfao A;
Cancer Med; 2020 Apr; 9(7):2317-2329. PubMed ID: 32022463
[TBL] [Abstract][Full Text] [Related]
8. CD4
Pan Y; Wang H; An F; Wu F; Tao Q; Li Y; Ruan Y; Zhai Z
Int Immunopharmacol; 2021 Jul; 96():107742. PubMed ID: 33984717
[TBL] [Abstract][Full Text] [Related]
9. Survival Rates of Adults With Acute Lymphoblastic Leukemia in a Low-Income Population: A Decade of Experience at a Single Institution in Mexico.
Jaime-Pérez JC; Jiménez-Castillo RA; Herrera-Garza JL; Gutiérrez-Aguirre H; Marfil-Rivera LJ; Gómez-Almaguer D
Clin Lymphoma Myeloma Leuk; 2017 Jan; 17(1):60-68. PubMed ID: 27600987
[TBL] [Abstract][Full Text] [Related]
10. Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
Park HS; Kim DY; Choi EJ; Lee JH; Lee JH; Jeon M; Kang YA; Lee YS; Seol M; Cho YU; Jang S; Chi HS; Lee KH; Park CJ
Acta Haematol; 2018; 139(4):220-227. PubMed ID: 29860259
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Short NJ; Kantarjian HM; Sasaki K; Cortes JE; Ravandi F; Thomas DA; Garcia-Manero G; Khouri I; Kebriaei P; Champlin RE; Pierce S; Issa GC; Konopleva M; Kadia TM; Bueso-Ramos C; Khoury JD; Jain N; O'Brien SM; Jabbour E
Cancer; 2016 Dec; 122(24):3812-3820. PubMed ID: 27508525
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow biopsy in adult acute lymphoblastic leukemia: morphological characteristics and contribution to the study of prognostic factors.
Thomas X; Le QH; Danaïla C; Lhéritier V; Ffrench M
Leuk Res; 2002 Oct; 26(10):909-18. PubMed ID: 12163052
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
14. Histone Deacetylase Inhibition with Panobinostat Combined with Intensive Induction Chemotherapy in Older Patients with Acute Myeloid Leukemia: Phase I Study Results.
Wieduwilt MJ; Pawlowska N; Thomas S; Olin R; Logan AC; Damon LE; Martin T; Kang M; Sayre PH; Boyer W; Gaensler KML; Anderson K; Munster PN; Andreadis C
Clin Cancer Res; 2019 Aug; 25(16):4917-4923. PubMed ID: 31152020
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab.
Topp MS; Gökbuget N; Zugmaier G; Stein AS; Dombret H; Chen Y; Ribera JM; Bargou RC; Horst HA; Kantarjian HM
Cancer; 2021 Feb; 127(4):554-559. PubMed ID: 33141929
[TBL] [Abstract][Full Text] [Related]
16. Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of allogeneic stem-cell transplantation.
Chen Y; Cortes J; Estrov Z; Faderl S; Qiao W; Abruzzo L; Garcia-Manero G; Pierce S; Huang X; Kebriaei P; Kadia T; De Lima M; Kantarjian H; Ravandi F
J Clin Oncol; 2011 Jun; 29(18):2507-13. PubMed ID: 21555694
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent response of lymphocytes in the induction of the linker histone variant, H1 degrees and histone H4 acetylation after treatment with the histone deacetylase inhibitor, trichostatin A.
Kypreou KP; Sourlingas TG; Sekeri-Pataryas KE
Exp Gerontol; 2004 Apr; 39(4):469-79. PubMed ID: 15050280
[TBL] [Abstract][Full Text] [Related]
18. Levels of the soluble, 55-kilodalton isoform of tumor necrosis factor receptor in bone marrow are correlated with the clinical outcome of children with acute lymphoblastic leukemia in first recurrence.
Wu S; Korte A; Gessner R; Henze G; Seeger K
Cancer; 2003 Aug; 98(3):625-31. PubMed ID: 12879482
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
Bührer C; Hartmann R; Fengler R; Rath B; Schrappe M; Janka-Schaub G; Henze G
J Clin Oncol; 1996 Oct; 14(10):2812-7. PubMed ID: 8874343
[TBL] [Abstract][Full Text] [Related]
20. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
[No Abstract] [Full Text] [Related]
[Next] [New Search]